Global Alliance for TB Drug Development, also known as TB Alliance, is a nonprofit organization that specializes in the development of new treatments for treating tuberculosis. Established in 2000, the organization strives to ensure the widespread availability of affordable, faster and better tuberculosis drug regimens that will advance global health and prosperity. Global Alliance for TB Drug Development is a member of the Stop TB Partnership. It operates as a virtual research and development organization and is involved in acquiring, licensing and developing products. Global Alliance for TB Drug Development is located in New York City.

Website: tballiance.org

Phone: (212) 227-7540

Cross Streets: Between William St and Broad St/Nassau St